Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 23.18 USD -1.15% Market Closed
Market Cap: 1.1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+45%
Revenue
Forecast
+3%
Operating Income
Forecast
+9%
Net Income
Forecast
+5%

Wall Street
Price Targets

AMPH Price Targets Summary
Amphastar Pharmaceuticals Inc

Wall Street analysts forecast AMPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMPH is 33.66 USD with a low forecast of 29.29 USD and a high forecast of 39.9 USD.

AMPH Lowest Forecast
Wall Street Target
29.29 USD
26% Upside
AMPH Average Forecast
Wall Street Target
33.66 USD
45% Upside
AMPH Highest Forecast
Wall Street Target
39.9 USD
72% Upside
Lowest
Price Target
29.29 USD
26% Upside
Average
Price Target
33.66 USD
45% Upside
Highest
Price Target
39.9 USD
72% Upside
Amphastar Pharmaceuticals Inc Competitors:
Price Targets
S
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
35% Downside
LQDA
Liquidia Corp
145% Upside
NWRN
Newron Pharmaceuticals SpA
151% Upside
S
SBBC
Simply Better Brands Corp
170% Upside
S
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
35% Downside
LQDA
Liquidia Corp
145% Upside
NWRN
Newron Pharmaceuticals SpA
151% Upside
S
SBBC
Simply Better Brands Corp
170% Upside
INDOCO
Indoco Remedies Ltd
13% Downside
S
4565
Sosei Group Corp
100% Upside
1477
Ocumension Therapeutics
30% Downside
4151
Kyowa Kirin Co Ltd
11% Upside

Revenue
Forecast

Revenue Estimate
Amphastar Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is 3%.

14%
Past Growth
3%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Amphastar Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's operating income is 38%. The projected CAGR for the next 3 years is 9%.

38%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-19%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Amphastar Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's net income is 42%. The projected CAGR for the next 3 years is 5%.

42%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

See Also

Summary
AMPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMPH stock valuation using valuation multiples.
Wall Street Estimates
AMPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMPH's stock price target?
Price Target
33.66 USD

According to Wall Street analysts, the average 1-year price target for AMPH is 33.66 USD with a low forecast of 29.29 USD and a high forecast of 39.9 USD.

What is Amphastar Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is 3%.

What is Amphastar Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's operating income is 38%. The projected CAGR for the next 3 years is 9%.

What is Amphastar Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's net income is 42%. The projected CAGR for the next 3 years is 5%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 264,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.